Back to search

Article

Expanding Microgel Parameters to Model the Tumor Microenvironment and Examine Temozolomide Resistance in Glioblastoma

2026-07-09

Abstract excerpt

<h4>ABSTRACT</h4> Glioblastoma (GBM) is a highly aggressive brain tumor with a five-year survival rate of less than 5%. The current standard of care established 20 years ago includes maximal surgical resection and administration of alkylating agent temozolomide (TMZ). GBM is highly invasive, and GBM cells that evade surgical resection can become resistant to TMZ and develop new aggressive secondary tumors. Post-r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
47b2910b-f83a-5a5b-855a-9db4563f1ea9
DOI
10.64898/2026.07.08.737105
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Expanding Microgel Parameters to Model the Tumor Microenvironment and Examine Temozolomide Resistance in GlioblastomaDOI 10.64898/2026.07.08.737105
Select a neighboring publication to make it the new centre.